STAAR Surgical Shares Jump After Blowout Q1 2026 Results and China Momentum
STAAR Surgical jumped sharply in morning trading after reporting first-quarter 2026 results that materially outperformed expectations. The company posted EPS of $0.10 and revenue of $93.5 million, driven largely by momentum in China following the January launch of the EVO+ ICL and progress resolving distributor inventory issues. Analyst upgrades an…